Brooke Carroll
Family Medicine · Centreville, ALNPI 1508389180
Payments from drug & device makers
Across 121 payments — averaging $17.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$460
- Bayer$406
- GSK$180
- Pfizer$156
- Lilly USA, LLC$134
- Amgen$128
- plus $618 from 16 others
What the payments were for
- Food & beverage$2,082100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 30 | $460 |
| Bayer | 24 | $406 |
| GSK | 10 | $180 |
| Pfizer | 9 | $156 |
| Lilly USA, LLC | 8 | $134 |
| Amgen | 7 | $128 |
| AbbVie | 5 | $87 |
| Novartis | 4 | $72 |
| Dexcom, Inc. | 4 | $70 |
| AstraZeneca | 4 | $67 |
| Astellas Pharma US Inc | 3 | $62 |
| Abbott | 2 | $46 |
| Inogen, Inc. | 1 | $33 |
| Purdue Pharma L.p. | 2 | $31 |
| Regeneron Healthcare Solutions, Inc. | 1 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Boehringer Ingelheim | 1 | $20 |
| Axonics, Inc. | 1 | $19 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
| Shield Therapeutics Inc | 1 | $14 |
| Nestle Healthcare Nutrition Inc. | 1 | $13 |
How this compares
$2,082 in reported general payments places this provider in the 65th percentile of 1,680 family medicine providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 62 | $64,478 |
| OzempicSemaglutide | 39 | $48,956 |
| EliquisApixaban | 37 | $43,558 |
| FarxigaDapagliflozin Propanediol | 25 | $41,438 |
| LinzessLinaclotide | 35 | $29,592 |
| JardianceEmpagliflozin | 30 | $25,639 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 12 | $23,909 |
| XareltoRivaroxaban | 14 | $17,518 |
| VascepaIcosapent Ethyl | 13 | $7,171 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 35 | $5,939 |
| Atorvastatin Calcium | 387 | $4,371 |
| Rosuvastatin Calcium | 117 | $2,829 |
| Pravastatin Sodium | 68 | $2,438 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 98 | $2,241 |
| Omeprazole | 131 | $2,199 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $134 | $64,47862 claims |
| Boehringer IngelheimJardiance, Synjardy Xr | $20 | $49,54842 claims |
| Novo NordiskOzempic | $460 | $48,95639 claims |
| PfizerEliquis | $156 | $43,55837 claims |
| AstraZenecaFarxiga | $67 | $41,43825 claims |
| AbbVieLinzess | $87 | $29,59235 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,680 family medicine providers in Alabama.
Other family medicine in Centreville
- John WaitsCentreville$349K
- Michael VaughnBirmingham$9.9M
- William NixonGuntersville$7.1M
- Randall QuinnCullman$5.4M
- Matthew CaldwellAthens$4.1M
- Michael CarterHuntsville$3.4M
- Howard RubensteinSaraland$3.3M
- Randle MiddletonHuntsville$3.3M
- Aaron KarrSheffield$3.1M
- Nidal MorrarFoley$3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.